Esther Rajavelu

Insider Reports History

Entity
Individual
Location
26 Landsdowne Street, Cambridge, MA
Signature
Maegan Deare, attorney-in-fact for Esther Rajavelu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Esther Rajavelu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. CFO & CBO Common Stock 379K $493K $1.30 Nov 8, 2024 Direct
Fulcrum Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 160K Feb 9, 2023 Direct

Insider Reports Filed by Esther Rajavelu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRO Spero Therapeutics, Inc. Nov 7, 2024 2 -$53K 4 Nov 12, 2024 CFO & CBO
SPRO Spero Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 Chief Financial Officer and Chief Business Officer
SPRO Spero Therapeutics, Inc. Nov 13, 2023 1 $0 4 Nov 15, 2023 Chief Financial Officer and Chief Business Officer
SPRO Spero Therapeutics, Inc. Nov 6, 2023 0 $0 3 Nov 15, 2023 Chief Financial Officer and Chief Business Officer Exhibit 24.1 - Power of Attorney
FULC Fulcrum Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Chief Financial Officer
FULC Fulcrum Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 10, 2022 Chief Financial Officer
FULC Fulcrum Therapeutics, Inc. Jan 3, 2022 0 $0 3 Jan 10, 2022 Chief Financial Officer